Thrivent Financial for Lutherans’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $135M | Sell |
972,007
-7,026
| -0.7% | -$984K | 0.26% | 80 |
|
|
2025
Q4 | $120M | Buy |
979,033
+6,045
| +0.6% | +$735K | 0.21% | 98 |
|
|
2025
Q3 | $108M | Buy |
972,988
+165,304
| +20% | +$18.8M | 0.21% | 103 |
|
|
2025
Q2 | $89.5M | Sell |
807,684
-238,111
| -23% | -$25.3M | 0.2% | 129 |
|
|
2025
Q1 | $117M | Sell |
1,045,795
-140,876
| -12% | -$14.5M | 0.26% | 86 |
|
|
2024
Q4 | $110M | Sell |
1,186,671
-1,000,775
| -46% | -$90.1M | 0.21% | 101 |
|
|
2024
Q3 | $183M | Buy |
2,187,446
+28,090
| +1% | +$2.14M | 0.35% | 55 |
|
|
2024
Q2 | $148M | Buy |
2,159,356
+1,262,193
| +141% | +$84.2M | 0.3% | 68 |
|
|
2024
Q1 | $65.7M | Sell |
897,163
-551,858
| -38% | -$42.4M | 0.13% | 209 |
|
|
2023
Q4 | $117M | Sell |
1,449,021
-65,616
| -4% | -$5.11M | 0.26% | 99 |
|
|
2023
Q3 | $114M | Sell |
1,514,637
-87,866
| -5% | -$6.76M | 0.27% | 90 |
|
|
2023
Q2 | $124M | Buy |
1,602,503
+4,618
| +0.3% | +$368K | 0.28% | 83 |
|
|
2023
Q1 | $133M | Sell |
1,597,885
-283,937
| -15% | -$23.5M | 0.32% | 66 |
|
|
2022
Q4 | $162M | Buy |
1,881,822
+36,782
| +2% | +$2.91M | 0.42% | 39 |
|
|
2022
Q3 | $114M | Buy |
1,845,040
+939,524
| +104% | +$59.2M | 0.31% | 69 |
|
|
2022
Q2 | $56M | Sell |
905,516
-163,077
| -15% | -$10.1M | 0.15% | 184 |
|
|
2022
Q1 | $63.5M | Buy |
1,068,593
+281,300
| +36% | +$18M | 0.12% | 205 |
|
|
2021
Q4 | $57.1M | Buy |
787,293
+85,476
| +12% | +$5.89M | 0.11% | 231 |
|
|
2021
Q3 | $49M | Buy |
701,817
+143,040
| +26% | +$10M | 0.1% | 241 |
|
|
2021
Q2 | $38.5M | Buy |
558,777
+239,091
| +75% | +$16M | 0.08% | 295 |
|
|
2021
Q1 | $20.7M | Sell |
319,686
-47,979
| -13% | -$3.09M | 0.05% | 437 |
|
|
2020
Q4 | $21.4M | Sell |
367,665
-237,847
| -39% | -$14.4M | 0.05% | 431 |
|
|
2020
Q3 | $38.3M | Buy |
605,512
+32,931
| +6% | +$2.28M | 0.1% | 238 |
|
|
2020
Q2 | $44.1M | Sell |
572,581
-12,252
| -2% | -$939K | 0.13% | 194 |
|
|
2020
Q1 | $43.7M | Sell |
584,833
-1,174,470
| -67% | -$81.2M | 0.16% | 159 |
|
|
2019
Q4 | $114M | Sell |
1,759,303
-72,482
| -4% | -$4.72M | 0.33% | 62 |
|
|
2019
Q3 | $116M | Buy |
1,831,785
+86,228
| +5% | +$5.64M | 0.36% | 58 |
|
|
2019
Q2 | $118M | Buy |
1,745,557
+431,799
| +33% | +$28.4M | 0.36% | 58 |
|
|
2019
Q1 | $85.4M | Buy |
1,313,758
+317,232
| +32% | +$21.1M | 0.27% | 86 |
|
|
2018
Q4 | $62.3M | Buy |
996,526
+99,308
| +11% | +$6.94M | 0.23% | 108 |
|
|
2018
Q3 | $69.3M | Buy |
897,218
+842,620
| +1,543% | +$63.6M | 0.22% | 107 |
|
|
2018
Q2 | $3.87M | Buy |
54,598
+83
| +0.2% | +$5.86K | 0.01% | 715 |
|
|
2018
Q1 | $4.11M | Buy |
54,515
+1,160
| +2% | +$92.2K | 0.01% | 691 |
|
|
2017
Q4 | $3.82M | Buy |
53,355
+1,191
| +2% | +$90.4K | 0.01% | 721 |
|
|
2017
Q3 | $4.23M | Buy |
52,164
+2,534
| +5% | +$194K | 0.01% | 658 |
|
|
2017
Q2 | $3.51M | Sell |
49,630
-1,669,249
| -97% | -$111M | 0.01% | 682 |
|
|
2017
Q1 | $117M | Sell |
1,718,879
-544,210
| -24% | -$38.3M | 0.51% | 44 |
|
|
2016
Q4 | $162M | Buy |
2,263,089
+56,110
| +3% | +$4.17M | 0.72% | 24 |
|
|
2016
Q3 | $175M | Buy |
2,206,979
+469,250
| +27% | +$38.1M | 0.8% | 17 |
|
|
2016
Q2 | $145M | Sell |
1,737,729
-49,012
| -3% | -$4.35M | 0.69% | 28 |
|
|
2016
Q1 | $164M | Buy |
1,786,741
+246,180
| +16% | +$22.2M | 0.79% | 23 |
|
|
2015
Q4 | $156M | Buy |
1,540,561
+158,282
| +11% | +$16.5M | 0.75% | 28 |
|
|
2015
Q3 | $136M | Sell |
1,382,279
-300,592
| -18% | -$33.4M | 0.71% | 28 |
|
|
2015
Q2 | $197M | Sell |
1,682,871
-95,495
| -5% | -$10.4M | 1.09% | 9 |
|
|
2015
Q1 | $175M | Sell |
1,778,366
-297,435
| -14% | -$30.2M | 0.97% | 13 |
|
|
2014
Q4 | $196M | Sell |
2,075,801
-395,505
| -16% | -$40.9M | 1.08% | 9 |
|
|
2014
Q3 | $263M | Sell |
2,471,306
-555,653
| -18% | -$54.4M | 1.51% | 3 |
|
|
2014
Q2 | $251M | Sell |
3,026,959
-215,250
| -7% | -$16.8M | 1.41% | 4 |
|
|
2014
Q1 | $230M | Buy |
3,242,209
+81,250
| +3% | +$6.37M | 1.42% | 3 |
|
|
2013
Q4 | $237M | Buy |
3,160,959
+24,250
| +0.8% | +$1.69M | 1.45% | 4 |
|
|
2013
Q3 | $197M | Sell |
3,136,709
-140,591
| -4% | -$8.4M | 1.25% | 7 |
|
|
2013
Q2 | $168K | Buy |
+3,277,300
| New | +$171M | 1.09% | 11 |
|
Other funds holding GILD
VCM
VPM
Thrivent Financial for Lutherans's GILD Position: Q1 2026 in Review
Thrivent Financial for Lutherans reduced its Gilead Sciences (GILD) stake by 0.72% in Q1 2026, selling an estimated $984K and leaving 972,007 shares worth $135M. The position accounts for 0.26% of the portfolio, ranked #80.
Thrivent Financial for Lutherans first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $263M in Q3 2014. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Thrivent Financial for Lutherans held 972,007 shares of Gilead Sciences worth $135M as of Q1 2026.
- Thrivent Financial for Lutherans sold 7,026 Gilead Sciences shares in Q1 2026, an estimated $984K.
- Gilead Sciences made up 0.26% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #80 holding.
- Thrivent Financial for Lutherans first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Thrivent Financial for Lutherans's Gilead Sciences position peaked at $263M in Q3 2014.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.